Thus, persistent high lipid not only decreases UCP1 expression but also synergizes with UCP1 decrease to promote NK cell necroptosis and then facilitate NASH progression to fibrosis. This evidence concerns the gene UCP1 and metabolic dysfunction-associated steatohepatitis.